Alphamab Oncology Announces Anti-HER2 Biparatopic ADC JSKN003 Obtained Orphan Drug Designation from the U.S. FDA for the Treatment of GC/GEJ - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # Alphamab Oncology Announces Anti-HER2 Biparatopic ADC JSKN003 Obtained Orphan Drug Designation from the U.S. FDA for the Treatment of GC/GEJ ##### Up next ![A Blueprint for Beauty: Meiyume Indonesia's Interactive Showcase Brings Insights-driven Innovation to Life](https://i0.wp.com/r2.thailandbusinessnews.net/2025/07/Meiyume_Your_Beauty_Blueprint_Press_Release.jpg?resize=200%2C110&ssl=1 "A Blueprint for Beauty: Meiyume Indonesia's Interactive Showcase Brings Insights-driven Innovation to Life") [](https://thailandbusinessnews.net/press-release/a-blueprint-for-beauty-meiyume-indonesias-interactive-showcase-brings-insights-driven-innovation-to-life/) ###### [A Blueprint for Beauty: Meiyume Indonesia's Interactive Showcase Brings Insights-driven Innovation to Life](https://thailandbusinessnews.net/press-release/a-blueprint-for-beauty-meiyume-indonesias-interactive-showcase-brings-insights-driven-innovation-to-life/) Published on 29 July 2025 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) SUZHOU, China, July 29, 2025 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of gastric cancer and gastroesophageal junction cancer (GC/GEJ). GC/GEJ is the fifth most common cancer and the fifth leading cause of cancer death worldwide. According to the 2022 Global Cancer Statistics report released by the International Agency for Research on Cancer (IARC), a subsidiary of the World Health Organization, there are approximately 960,000 new cases diagnosed and 660,000 deaths worldwide annually. In the U.S., the SEER database model predicts that there will be 26,890 new cases and 10,880 new deaths of GC/GEJ in 2024, with a five-year overall survival rate of less than 40%. Fluoropyrimidine and platinum-based regimens are commonly used as first-line treatments. Available second-line or later-line treatment options include paclitaxel plus ramucirumab, paclitaxel, docetaxel or irinotecan monotherapy, and best supportive care, with objective response rates of approximately 15-25%. The median overall survival is approximately 8-9 months for second-line treatment and 4-6 months for later lines. JSKN003 is an anti-HER2 biparatopic ADC developed inhouse with Alphamab’s proprietary glycan-specific conjugation platform. The antibody molecule KN026 is site-specifically modified via enzyme catalytic reaction and click chemistry to achieve a drug-to-antibody ratio (DAR) of approximately 4. It can bind HER2 on the surface of tumor cells, and release topoisomerase I inhibitors (TOPIi) through cellular endocytosis, thereby exert anti-tumor effects. Compared with its ADC counterparts, JSKN003 demonstrated better serum stability and stronger bystander effect, which effectively expands the therapeutic window. Research results from the Phase I clinical study JSKN003-101 (NCT05494918) conducted in Australia and the Phase I/II clinical study JSKN003-102 (NCT05744427) in China have demonstrated favorable tolerability and safety profile, with promising efficacy of JSKN003 in heavily pretreated patients with advanced solid tumors, especially in patients with high HER2-expressing gastrointestinal tumors. Detailed data were presented at the 2024 European Society for Medical Oncology (ESMO) Congress for the first time and subsequently updated at the 2025 Annual Meeting of American Society of Clinical Oncology (ASCO) in June 2025. The "Orphan Drug Designation", originated from the Orphan Drug Act (ODA), is a U.S. FDA initiative aimed at encouraging the development of innovative drugs for the treatment of diseases affecting fewer than 200,000 people in the U.S. The designation of JSKN003 will be beneficial to obtain relevant policy supports for subsequent research and development, registration, and commercialization in the U.S., including funding for research and development costs, tax credits for clinical trial expenditures, waiver of prescription drug user fee, accelerated review and approval processes, and, upon approval, the potential for seven years of market exclusivity in the U.S. About JSKN003 JSKN003 is a bispecific ADC developed based on KN026 using Alphamab’s proprietary glycan-specific conjugation platform. JSKN003 can bind HER2 on the surface of tumor cells and release topoisomerase I inhibitors (TOPIi) through cellular endocytosis, thereby exerting anti-tumor effects. Compared with its ADC counterparts, JSKN003 demonstrated better serum stability and stronger bystander effect, which effectively expands the therapeutic window. Results of multiple clinical studies at various stages of JSKN003 in China and Australia have demonstrated favorable safety profile, with promising efficacy of JSKN003 in heavily pretreated patients with advanced solid tumors, especially in patients with platinum-resistant ovarian cancer (PROC), HER2-expressing breast cancer (BC), or high HER2-expressing solid tumors. JSKN003 was granted breakthrough therapy designation by CDE. The designation is for the treatment of platinum-resistant recurrent epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer. Three Phase III clinical studies of JSKN003 for the treatment of HER2-low expressing BC, PROC, and HER2-positive BC as well as multiple exploratory Phase II clinical studies are currently undergoing smoothly. In September 2024, the Company entered a licensing agreement with JMT-Bio Technology Co., Ltd. ("JMT-Bio"), a wholly-owned subsidiary of CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (stock code: 1093.HK), pursuant to which, JMT-Bio was granted the exclusive license and sublicense rights to develop, sell, offer for sale and commercialize JSKN003, for the treatment of tumor-related indications (the "Field") in mainland China (excluding Hong Kong, Macau or Taiwan) (the "Territory") and become the sole marketing authorization holder for JSKN003 for the Field in the Territory. Alphamab retains the sole right to supply JSKN003. About Alphamab Oncology Alphamab Oncology is an innovative biopharmaceutical company focusing on oncology therapeutics. On December 12, 2019, the Company was successfully listed on the Main Board of the Hong Kong Stock Exchange, trading under the stock code 9966. By leveraging its proprietary core technology platforms including single-domain antibodies, bispecific antibodies, glycan-specific conjugation, linker-payload, dual-payload antibody conjugation, and subcutaneous high concentration formulation for biologics, the Company has established a product portfolio with differentiated innovation and global competitiveness, covering cutting-edge areas such as antibody-drug conjugates (ADCs), bispecific antibodies, and single-domain antibodies. The Company has one product approved for marketing (Envafolimab, the world’s first subcutaneously injectable PD-(L)1 inhibitor), which has made a significant breakthrough in the convenience and accessibility of cancer treatment. Additionally, the Company has multiple bispecific antibodies and bispecific ADCs in clinical stage, while rapidly advancing the preclinical pipeline prioritizing bispecific ADCs and dual-payload ADCs. Multiple strategic collaborations based on innovative products or technology platforms have been established with partners such as CSPC, ArriVent, and Glenmark. Our overarching mission is to make cancer manageable and curable by addressing unmet clinical needs in oncology. Alphamab Oncology is continuously dedicated to the development of effective, safe, and globally competitive anti-tumor drugs, delivering China-innovated cancer therapies to benefit patients worldwide. [Source link ](https://www.prnasia.com/story/archive/4739402_AE39402_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/atfx-breaks-new-ground-with-usd-1-09-trillion-in-q1-2026-trading-volume/) ## ATFX Breaks New Ground with USD 1.09 Trillion in Q1 2026 Trading Volume HONG KONG, May 6, 2026 /PRNewswire/ — ATFX recorded USD 1.09 trillion… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - May 6, 2026 [](https://thailandbusinessnews.net/press-release/yiwu-global-digital-trade-center-nears-grand-opening-sparking-buzz-with-global-buyers-through-short-dramas-and-ai-driven-videos/) ## Yiwu Global Digital Trade Center Nears Grand Opening, Sparking Buzz with Global Buyers Through Short Dramas and AI-Driven Videos YIWU, China, Oct. 9, 2025 /PRNewswire/ — This autumn, Yiwu is poised… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - October 9, 2025 [](https://thailandbusinessnews.net/press-release/honor-launches-the-honor-400-series-with-the-leading-ai-camera-2/) ![HONOR Launches the HONOR 400 Series with the Leading AI Camera](https://i0.wp.com/r2.thailandbusinessnews.net/2025/05/HONOR_LOGO_Logo.jpg?resize=260%2C140&ssl=1 "HONOR Launches the HONOR 400 Series with the Leading AI Camera") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## HONOR Launches the HONOR 400 Series with the Leading AI Camera Elevating comprehensive photography experience on smartphones with the 200MP Ultra-clear AI Camera… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - May 22, 2025 ##### Most Read - [![OMNICOM MEDIA WAS AWARDED $3.3 BILLION IN NEW BILLINGS IN H1 2026, MORE THAN ANY OTHER GLOBAL MEDIA GROUP](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/omnicom-media-was-awarded-3-3-billion-in-new-billings-in-h1-2026-more-than-any-other-global-media-group/ "OMNICOM MEDIA WAS AWARDED $3.3 BILLION IN NEW BILLINGS IN H1 2026, MORE THAN ANY OTHER GLOBAL MEDIA GROUP") [OMNICOM MEDIA WAS AWARDED $3.3 BILLION IN NEW BILLINGS IN H1 2026, MORE THAN ANY OTHER GLOBAL MEDIA GROUP](https://thailandbusinessnews.net/press-release/omnicom-media-was-awarded-3-3-billion-in-new-billings-in-h1-2026-more-than-any-other-global-media-group/ "OMNICOM MEDIA WAS AWARDED $3.3 BILLION IN NEW BILLINGS IN H1 2026, MORE THAN ANY OTHER GLOBAL MEDIA GROUP") - [![Fortune Announces 2026 Fortune Global 500 List](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/fortune-announces-2026-fortune-global-500-list/ "Fortune Announces 2026 Fortune Global 500 List") [Fortune Announces 2026 Fortune Global 500 List](https://thailandbusinessnews.net/press-release/fortune-announces-2026-fortune-global-500-list/ "Fortune Announces 2026 Fortune Global 500 List") - [![Tencent Cloud and Boost Collaborate to Accelerate Digital Transformation Across Southeast Asia](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/tencent-cloud-and-boost-collaborate-to-accelerate-digital-transformation-across-southeast-asia/ "Tencent Cloud and Boost Collaborate to Accelerate Digital Transformation Across Southeast Asia") [Tencent Cloud and Boost Collaborate to Accelerate Digital Transformation Across Southeast Asia](https://thailandbusinessnews.net/press-release/tencent-cloud-and-boost-collaborate-to-accelerate-digital-transformation-across-southeast-asia/ "Tencent Cloud and Boost Collaborate to Accelerate Digital Transformation Across Southeast Asia") - [![TICA Showcases Integrated Data Center Cooling Solutions at ENGINEER & MARVEX 2026, Supporting AI Infrastructure Growth in Southeast Asia](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/tica-showcases-integrated-data-center-cooling-solutions-at-engineer-marvex-2026-supporting-ai-infrastructure-growth-in-southeast-asia/ "TICA Showcases Integrated Data Center Cooling Solutions at ENGINEER & MARVEX 2026, Supporting AI Infrastructure Growth in Southeast Asia") [TICA Showcases Integrated Data Center Cooling Solutions at ENGINEER & MARVEX 2026, Supporting AI Infrastructure Growth in Southeast Asia](https://thailandbusinessnews.net/press-release/tica-showcases-integrated-data-center-cooling-solutions-at-engineer-marvex-2026-supporting-ai-infrastructure-growth-in-southeast-asia/ "TICA Showcases Integrated Data Center Cooling Solutions at ENGINEER & MARVEX 2026, Supporting AI Infrastructure Growth in Southeast Asia") - [![RX BITEC Celebrates 40 Years with "METALEX 2026" Empowering Entrepreneurs to Transform Their Businessesfor the AI & Smart Metalworking Era](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/rx-bitec-celebrates-40-years-with-metalex-2026-empowering-entrepreneurs-to-transform-their-businessesfor-the-ai-smart-metalworking-era/ "RX BITEC Celebrates 40 Years with "METALEX 2026" Empowering Entrepreneurs to Transform Their Businessesfor the AI & Smart Metalworking Era") [RX BITEC Celebrates 40 Years with "METALEX 2026" Empowering Entrepreneurs to Transform Their Businessesfor the AI & Smart Metalworking Era](https://thailandbusinessnews.net/press-release/rx-bitec-celebrates-40-years-with-metalex-2026-empowering-entrepreneurs-to-transform-their-businessesfor-the-ai-smart-metalworking-era/ "RX BITEC Celebrates 40 Years with "METALEX 2026" Empowering Entrepreneurs to Transform Their Businessesfor the AI & Smart Metalworking Era") - [![Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/brii-biosciences-provides-corporate-update-and-reports-full-year-2024-financial-results/ "Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results") [Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results](https://thailandbusinessnews.net/press-release/brii-biosciences-provides-corporate-update-and-reports-full-year-2024-financial-results/ "Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/scamadviser-showcases-agentic-ai-safeguards-at-gasa-global-anti-scam-summit-america-2026/) ![ScamAdviser Showcases Agentic AI Safeguards at GASA Global Anti-Scam Summit America 2026](https://i0.wp.com/mmx.prnasia.com/media/MS1993616/20260922022500EDT_image_1.jpg?resize=260%2C140&ssl=1 "ScamAdviser Showcases Agentic AI Safeguards at GASA Global Anti-Scam Summit America 2026") ## ScamAdviser Showcases Agentic AI Safeguards at GASA Global Anti-Scam Summit America 2026 SAN FRANCISCO, Sept. 23, 2026 /PRNewswire/ — ScamAdviser, a leading brand in… [](https://thailandbusinessnews.net/press-release/akas-eos-sales-knowledge-engine-completes-pilot-with-one-of-the-worlds-largest-consumer-electronics-companies/) ## AKA's 'EOS' Sales Knowledge Engine Completes Pilot with One of the World's Largest Consumer Electronics Companies Results from an ongoing enterprise pilot show measurable gains in sales knowledge… [](https://thailandbusinessnews.net/press-release/gsme-and-teradyne-announce-strategic-partnership/) ![GSME and Teradyne Announce Strategic Partnership](https://i0.wp.com/mmx.prnasia.com/media/MS1662399/GSME-PNG1-Logo-Logo.jpg?resize=260%2C140&ssl=1 "GSME and Teradyne Announce Strategic Partnership") ## GSME and Teradyne Announce Strategic Partnership Collaboration to Accelerate Semiconductor Test Solutions for Hyperscaler AI,… [](https://thailandbusinessnews.net/press-release/bougerv-launches-dunerover-an-all-new-electric-beach-wagon-built-to-make-outdoor-hauling-effortless/) ![BougeRV Launches DuneRover, an All-New Electric Beach Wagon Built to Make Outdoor Hauling Effortless](https://i0.wp.com/mmx.prnasia.com/media/MS1992365/20260921014026EDT_image_1.jpg?resize=260%2C140&ssl=1 "BougeRV Launches DuneRover, an All-New Electric Beach Wagon Built to Make Outdoor Hauling Effortless") ## BougeRV Launches DuneRover, an All-New Electric Beach Wagon Built to Make Outdoor Hauling Effortless Kickstarter launch brings an $899 MSRP electric beach wagon to early backers…